Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ATP5B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | RFX7 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | CRTC1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | OVOS2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | ABCD4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | DPH3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | GOLGA8J | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | OR52N4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | NBPF19 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | PKD1L1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |